This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Sep 24;290(12):1580; author reply 1580.

doi: 10.1001/jama.290.12.1580-a.

Leukoreduction vs buffy-coat depletion and the safety of blood transfusion

Jonathan P Wallis

PMID: 14506115
DOI: 10.1001/jama.290.12.1580-a

Comment

Leukoreduction vs buffy-coat depletion and the safety of blood transfusion

Jonathan P Wallis. JAMA. 2003.

. 2003 Sep 24;290(12):1580; author reply 1580.

doi: 10.1001/jama.290.12.1580-a.

Author

Jonathan P Wallis

PMID: 14506115
DOI: 10.1001/jama.290.12.1580-a

No abstract available

PubMed Disclaimer

Comment on

Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.
Hébert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Schweitzer I, vanWalraven C, Devine D, Sher GD; Leukoreduction Study Investigators. Hébert PC, et al. JAMA. 2003 Apr 16;289(15):1941-9. doi: 10.1001/jama.289.15.1941. JAMA. 2003. PMID: 12697796

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems